Metoprolol in Coronary Artery Disease: Top 5 Evidence Insights Dr. S. N. Routray6 Feb 2025 11:41 AM ISTCoronary Artery Disease-A Concerning Epidemiology in India:India has the highest burden of acute coronary syndrome and ST-elevation myocardial...
Metoprolol: Applicability in Young Hypertensives in India Dr. Debopriyo Mondal11 Nov 2024 12:31 PM ISTHypertension affects 1 in 8 adults aged between 20 and 40 years. The prevalence of hypertension among adults in India is about 25 to 42% and three...
CVD Care Continuum in 2024: Metoprolol Revisited Dr Johann Christopher25 Oct 2024 11:02 AM ISTCoronary artery disease (CAD) is a significant group within cardiovascular diseases (CVD) that results from decreased myocardial perfusion, leading to...
Metoprolol: 20-Year Journey Down the Memory Lane Dr K. Sarat Chandra22 July 2024 12:30 PM ISTIntroduction (1-2)Over the past two decades, metoprolol has established its position in managing cardiovascular diseases. As a beta-1 selective...
Cherishing the 100th Birth Anniversary of Sir James Wyte Black-Pioneer of the First Clinically Significant Beta-Blocker Dr Vilas P. Magarkar14 Jun 2024 11:15 AM ISTThe 100th birth anniversary of Sir James Wyte Black is a momentous occasion to reflect on his monumental contributions to medicine, particularly...
Beta Blockers: A Five-Decade Legacy and Spotlight on Metoprolol Dr. Rajiv Karnik17 May 2024 11:00 AM ISTSince their introduction over five decades ago, beta-blockers have revolutionized the landscape of cardiovascular medicine. Initially developed to...
Ajanta Pharma Launches World's 1st FDC Met XL AMT for Patients with Uncontrolled Hypertension and Cardiovascular Co-morbidity in India MD Brand Connect8 Aug 2023 11:53 AM ISTAjanta Pharma, one of the leaders in the cardiology segment has announced the launch of Met XL AMT, a novel triple drug combination for the...
